article · TNHJPH
Background: Lassa fever remains a major public health threat in West Africa, with Nigeria accounting for the highest burden of disease. However, the true extent of population-level exposure is poorly defined, particularly in North-Central Nigeria. Methods: A community-based cross-sectional seroprevalence of LASV was conducted across five states in North-Central Nigeria (Benue, Kogi, Nasarawa, Plateau, and the Federal Capital Territory-FCT) between January and July 2024. A total of 958 participants were enrolled using a multistage sampling method. Serum samples were tested for LASV-specific IgG and IgM antibodies using a validated recombinant nucleoprotein enzyme-linked immunosorbent assay. All IgM-positive samples and a random subset of IgM-negative samples underwent RT-PCR testing for the detection of active infection. Standardised questionnaires captured sociodemographic, environmental, and behavioural exposures. Multivariable logistic regression was used to identify factors independently associated with seropositivity. Results: IgM seroprevalence was low (1.15%), and all 91 samples tested by RT-PCR were negative. In multivariable analysis, participants from FCT (adjusted odds ratio [aOR] 0.07, 95% CI 0.03–0.15), Kogi (aOR 0.05, 95% CI 0.02–0.14), Nasarawa (aOR 0.18, 95% CI 0.09–0.40), and Plateau (aOR 0.22, 95% CI 0.10–0.49) had significantly lower odds of IgG seropositivity compared to Benue State. Living in non-concrete houses was associated with increased odds of seropositivity (aOR 2.66, 95% CI 1.79–3.95). In contrast, rodent consumption was associated with reduced odds of seropositivity (aOR 0.23, 95% CI 0.12–0.44). Conclusion: LASV exposure is widespread but heterogeneously distributed across North-Central Nigeria, with strong influence from geographical and housing-related factors.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.71637/tnhj.v26i1.1390
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.